Partner Content Partner Content Exclusive Interview with ASBM Released Ahead of Upcoming Bio... Exclusive interview with expert speaker from ASBM
Views & Analysis Optimising market access for biosimilars We speak to Sandoz’s global head of biopharmaceuticals, Stefan Hendriks, about the remaining challenges in market access for biosimilars and what the future could hold for this still-bu
Views & Analysis Nine for 2019: Opportunities for pharma In the last Nine for 2019 article, we reflected on the major challenges that are sha
Partner Content Partner Content Michel Mikhail invites Biosimilar experts to attend SMi’s 10... Michel Mikhail invites Biosimilar experts to attend SMi
News Sandoz strikes deal with EirGenix for Herceptin biosimilar Sandoz has struck a deal with Taiwan-based EirGenix to market a late-stage biosimilar of Roche’s breast cancer blockbuster Herceptin.
Events Partner Content SMi’s 10th Annual Biosimilars Conference Biosimilars Conference, London, Sept 2019
News Repligen builds in cell therapy with $1.5bn BioLife takeover Repligen has reached a deal to buy cell therapy specialist BioLife Solutions for $1.5bn, tapping into a market growing at breakneck speed.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
